1. Home
  2. PLSE vs RPD Comparison

PLSE vs RPD Comparison

Compare PLSE & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

N/A

Current Price

$14.09

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Rapid7 Inc.

RPD

Rapid7 Inc.

N/A

Current Price

$15.75

Market Cap

1.0B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PLSE
RPD
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
PLSE
RPD
Price
$14.09
$15.75
Analyst Decision
Buy
Hold
Analyst Count
1
21
Target Price
$22.00
$24.00
AVG Volume (30 Days)
183.4K
1.2M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.35
Revenue
$86,000.00
$858,667,000.00
Revenue This Year
N/A
$2.63
Revenue Next Year
$1,002.94
$1.65
P/E Ratio
N/A
$46.97
Revenue Growth
N/A
3.08
52 Week Low
$12.56
$13.21
52 Week High
$25.00
$42.09

Technical Indicators

Market Signals
Indicator
PLSE
RPD
Relative Strength Index (RSI) 47.40 46.12
Support Level $13.12 $15.73
Resistance Level $14.75 $16.88
Average True Range (ATR) 0.61 0.52
MACD 0.22 0.14
Stochastic Oscillator 58.33 20.54

Price Performance

Historical Comparison
PLSE
RPD

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Share on Social Networks: